About 80% of people with cancer suffer from significant muscle wasting, or loss of muscle tissue, and 30% of these patients die from this condition. New research in mice finds that the severity of muscle wasting is related ...
Dec 2, 2022
0
103
Antibiotics routinely used in ovarian cancer care indiscriminately kill gut bacteria, leading to faster cancer progression and lower survival rates, according to recent Cleveland Clinic research.
Nov 8, 2022
0
36
Researchers from the University of Minnesota have discovered that a protein associated with metabolism, and formerly recognized as a potential therapeutic target for ovarian cancer, may instead be associated with a better ...
Jul 20, 2022
0
9
Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or in combination with another anticancer drug (pembrolizumab) may be effective in treating several types of late-stage cancers ...
May 26, 2022
0
20
A new chimeric antigen receptor (CAR) T-cell product had an acceptable safety profile and showed early signs of efficacy as a monotherapy and in combination with an mRNA vaccine in patients with solid tumors, according to ...
Apr 10, 2022
0
15
Every year, roughly 550 women develop ovarian cancer in Finland. Ovarian cancer is difficult to treat and it is commonly fatal, with 320 women dying of ovarian cancer annually in Finland.
Feb 11, 2022
0
12
Ovarian granulosa cell tumors are a rare type of ovarian cancer that affect the ovaries and fallopian tubes, and can extend further into the pelvis and lymph nodes. Treatment typically follows the same guidelines as other ...
Dec 3, 2021
0
4
Early detection of ovarian cancer helps boost a woman's survival, and the U.S. Food and Drug Administration on Monday approved a new imaging drug that can help spot tumors during surgery.
Nov 29, 2021
0
0
A group of scientists at the Suzhou Institute of Biomedical Engineering and Technology (SIBET) of the Chinese Academy of Sciences proposed a new method with Modality-based Attention and Contextual (MAC)-Net to better help ...
Nov 9, 2021
0
19
A Ludwig Cancer Research study has uncovered a cellular interaction that is essential to the ability of the immune system's cytotoxic T lymphocytes to destroy ovarian tumors and shown that its engagement could help determine ...
Nov 6, 2021
0
78
